Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
Clinical trial NCT03201757 · COMPLETED
Trial details
- NCT number
- NCT03201757
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2023-09-06
- Enrollment
- 523
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.